X0508 4 2024-09-20 false 0001710072 Edgewise Therapeutics, Inc. EWTX 0001853529 Russell Alan J C/O EDGEWISE THERAPEUTICS, INC. 1715 38TH STREET BOULDER CO 80301 true true false false Chief Scientific Officer false Common Stock 2024-09-20 4 M false 75000.00 0.18 A 87719.00 D Common Stock 2024-09-20 4 S false 74185.00 28.2544 D 13534.00 D Common Stock 2024-09-20 4 S false 815.00 29.5074 D 12719.00 D Stock Option (Right to Buy) 0.18 2024-09-20 4 M false 75000.00 0.00 D 2032-06-27 Common Stock 75000.00 1456780.00 D Includes 2,968 shares purchased on May 15, 2023, 2,088 shares purchased on November 15, 2023 and 425 shares purchased on May 15, 2024 pursuant to the Edgewise Therapeutics, Inc. 2021 Employee Stock Purchase Plan. The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $28.02 to $28.47, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $29.50 to $29.56, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. 1/48th of the shares subject to the option vested each month beginning on June 27, 2017. /s/ John R. Moore, Attorney-in-Fact for Russell Alan J 2024-09-20